BAIN CAPITAL INVESTORS LLC

Q3 2021 13F-HR Holdings

Location
Boston, MA
Holdings as of
9/30/2021
Date filed
11/15/2021
Form type
13F-HR
Num holdings
6
Total value ($000)
$8,480
Net value change ($000)
-1,762 (-17.2%)
New positions
0
Sold out positions
1
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/16/2021 Next filing: 2/14/2022 SEC filing

Snapshot: Change Analysis

Compared to Q2 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Cerevel Therapeutics Holdings, Inc. 236 15.2%
Top Reduces (Value $000, Stocks/ETFs)
SGRY -1,192 -36.5%
DIVERSEY HLDGS LTD -442 -10.4%
AVAH -352 -35.1%
ADV -6 -19.4%
Atento S.A. -4 -100.0%
IQV -2 -1.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type